$MKTW

MarketWise Reports Net Revenue of $81.3 Million and Net Income of $17.9 Million for Third Quarter 2025; Third Quarter Billings Increased 30% YoY; Announced Quarterly and Special Dividend Totaling $0.40 per Class A Share, for Total FY 2025 Dividends of $1.90 Per Share, or a 13% Cash Yield; Provides Preliminary Targets for FY 2026, Including a 50% Planned Increase in CFFO

BALTIMORE, Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- MarketWise, Inc. ( NASDAQ: MKTW ) ( "MarketWise" or the "Company" ) , a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, today reported ...

Original reporting
GlobeNewswire · MarketWise LLC
Published Nov 6, 2025, 9:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 7, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MarketWise Reports Net Revenue of $81.3 Million and Net Income of $17.9 Million for Third Quarter 2025; Third Quarter Billings Increased 30% YoY; Announced Quarterly and Special Dividend Totaling $0.40 per Class A Share, for Total FY 2025 Dividends of $1.90 Per Share, or a 13% Cash Yield; Provides Preliminary Targets for FY 2026, Including a 50% Planned Increase in CFFO — source image
Decision brief

The 30-second read

$MKTWBullishHigh
01

Why it matters

The company's solid financial performance and attractive dividend policy position it favorably among growth and income investors, potentially driving stock appreciation.

02

Market read

The news is highly relevant for investors interested in growth and income opportunities within the financial technology sector, especially those focusing on dividend-paying stocks.

03

What to watch

Market saturation in digital subscription services; increased competition could pressure margins and stock performance.

Relevance 6/10Timing: Immediate, given recent earnings release and dividend declaration.

Background

MarketWise reported strong Q3 2025 financial results, including a 30% YoY increase in billings, and announced dividends totaling $0.40 per share for the quarter, with an annual dividend yield of 13%. The company provided preliminary FY 2026 targets, including a 50% increase in CFFO.

Company-level read

Ticker impact

$MKTWBullishHigh confidence
Context

Primary focus due to company's strong quarterly performance and dividend announcement.

Expected impact

Moderate upward movement in stock price over the short to medium term.

Evidence & confidence

Strong revenue growth, increased billings, and dividend announcements suggest positive investor sentiment and potential price appreciation.

Market effects

Positive outlook for the financial services and digital subscription sectors due to strong earnings and growth prospects.

Limited regional impact; primarily relevant to North American markets.

Moderate, as the company operates in a global digital services environment but is primarily US-focused.

Counterpoint

Potential overvaluation if future growth does not meet expectations; dividend sustainability could be challenged if margins decline.

Key entities

  • MarketWise, Inc.

    A leading digital subscription services platform providing financial research, software, education, and tools.

Related articles

$MKTWMed

MarketWise Reports Q2 Billings Increase of 57% YoY to $91.2 Million and Q2 CFFO Increase of 25.7% to $22.4 million; Net Revenue of $75.8 Million and Net Loss…

MARKETWISE, INC. (MKTW) filed an SEC Form 8-K — Results of Operations and Financial Condition. MarketWise Reports Q2 Billings Increase of 57% YoY to $91.2 Million and Q2 CFFO Increase of 25.7% to $22.4 million; Net Revenue of $75.8 Million and Net Loss of $2.6 Million for Second Quarter 2026; Raises FY 2026 Billings Guidance 10% to $330 million; Affirms FY 2026 Dividend Ta

$MKTWMed

MarketWise, Inc. Reports Preliminary Selected Unaudited Second Quarter Results With Paid Subscriber Growth Continuing In The Second Quarter 2026; Billings…

MARKETWISE, INC. (MKTW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-financialandope.htm EX-99.1 Document MarketWise, Inc. Reports Preliminary Selected Unaudited Second Quarter Results With Paid Subscriber Growth Continuing In The Second Quarter 2026; Billings Increased 56% Year-Over-Year To Approximately $91 million ; Raises

$PPCBMed

Propanc Biopharma targets February 2027 for first patient screening

Propanc Biopharma (PPCB) aims to begin patient screening for its cancer treatment PPC-001 in February 2027. The Phase 1b study will involve up to 50 patients with solid tumors in Australia. The company is finalizing clinical protocols and site assessments, with regulatory submissions planned for early 2027. PPC-001 has received FDA Orphan Drug Designation for pancreatic cancer.

$EMATMed

Evolution Metals & Technologies Confirms Delivery of All 57 ULVAC Equipment Containers to Pohang Expansion Site, with Commissioning Under Way at the Largest…

Evolution Metals & Technologies Corp. (EMAT) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Evolution Metals & Technologies Confirms Delivery of All 57 ULVAC Equipment Containers to Pohang Expansion Site, with Commissioning Under Way at the Largest Expected High-Performance Rare Earth Magnet Facility Outside China Equipment secured in months against industr